Breaking the Barriers in Medication-Assisted Treatment for Opioid Use Disorder

Breaking the Barriers in Medication-Assisted Treatment for Opioid Use Disorder

On-Demand Webcast

Arwen Podesta, MD, ABPN, FASAM, ABIHM
Assistant Professor of Psychiatry
Tulane University
Medical Director
Owner/Psychiatrist Podesta Wellness
New Orleans, Louisiana

Q&A Panel

Jacqueline Cleary, PharmD, BCACP 
Assistant Professor  
Albany College of Pharmacy and Health Sciences
Pain and Palliative Care Pharmacy 
Albany Stratton VA Hospital 
Albany, New York

(Judge) Jodi Debbrecht Switalski
Former Judge, Attorney, Consultant, National Presenter
Founder and Chief Consultant, Switalski Law & Consulting LLC
Partner, The Stutman Switalski Group LLC
Of Counsel, Lippitt O'Keefe Gornbein PLLC
Detroit, Michigan

Leigh Ann de Monredon, C-ANP, MSN
Substance Use Disorder Program Strategist
Saint Thomas Community Health Center (FQHC)
New Orleans, Louisiana

Adam Rivas, LPC
Mentalfitness LLC
Odyssey House Louisiana
New Orleans, Louisiana


This activity is designed for all stakeholders in OUD management, including front-line clinicians such as physicians, nurses, and other addiction management medical professionals; counselors and therapists; executive-level decision makers at for-profit, not-for-profit, public, and private mental health and substance use treatment organizations; policy makers; prevention and public health officials; law enforcement personnel; and community advocates.


After completing this activity, participants should be able to:

  • Outline the current evidence supporting the use of MAT to improve outcomes in OUD
  • Evaluate available and emerging long-acting formulations of OUD pharmacotherapies with respect to their mechanisms of action, efficacy, safety, routes of administration, and regulatory and access considerations for appropriate use
  • Describe the specific needs, barriers, and considerations of OUD treatment in special settings, including the criminal justice system, Veterans Health Administration, inpatient, and outpatient facilities
  • Implement strategies to overcome barriers to effective implementation of MAT in OUD management

In order to be eligible for documentation of credit, participants must complete the pre-test, attend the full webinar, complete the 10-question post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at, where participants may immediately print their documentation of credit. Participants will be asked to complete a pre-activity survey, post-activity survey and evaluation following the educational session. Participants will be asked to log in or create an account at

Release Date: March 28, 2019
Expiration Date: March 28, 2020
Estimated Time to Complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to


 In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 credit.


This continuing nursing education activity awards 1 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.


This enduring activity is approved for 1 contact hour (.01 CEUs) of continuing pharmacy education (UAN JA0006201-9999-18-240-H01-P).

This educational activity is a knowledge-based activity.

ACPE Credit Policy

The certificate is not the official record of your participation in the activity. The official record of credit will be the information in CPE Monitor system.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. The reporting function into CPE Monitor will only be available for 60 days after your completion of the activity.  Under ACPE Policy, Imedex will not be able to report your credit to CPE Monitor after this 60 day period.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.


North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.

Instructional Level: Advanced


NACCME is approved as a provider for social work continuing education by the Association of State Social Work Boards (ASWB), in being a Jointly Accredited Provider. NACCME maintains responsibility for the program. ASWB Approval Period:  Social workers should contact their regulatory board to determine course approval. Social workers participating in this course will receive up to 1 continuing education clock hour.

Addiction Professionals

This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840.  NACCME is responsible for all aspects of the programing.

EMS Personnel

This CE activity is accredited by the Commission on Accreditation for Pre-hospital Continuing Education (CAPCE) for 1.0 Advanced Level CEH.

Law Enforcement

This activity, course #: DXN06G, has been approved by the Georgia Peace Officer Standards and Training Council for 1.0 hour of training credit.

Planning Committee

The planning committee is comprised of Leigh Ann de Monredon, C-ANP, MSN, (Judge) Jodi Debbrecht Switalski, Arwen Podesta, MD, ABPN, FASAM, ABIHM, Adam Rivas, LPC,; Randy Robbin, Margie Stefan, Susan Yarbrough, NACCME; Doug Edwards, IABH; and Tyler Gibson, CE Learning Systems.

Independent Clinical Reviewer: Douglas L. Noordsy, MD, Clinical Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Director of Sports Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Podesta: Speaker—Alkermes, Jaymac Pharmaceuticals LLC, Orexo.

Ms. SeamanAdvisory Board—Mölnlycke

Ms. Cleary, (Judge) Debbrecht Switalski, Ms. de Monredon, Dr. Noordsy, and Dr. Rivas, have disclosed no relevant financial relationships with any commercial interests.

Mr. Edwards, Mr. Gibson, Mr. Robbin, Ms. Stefan, and Ms.Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity is supported by an educational grant from Alkermes, INC.